Index of /wp-content/uploads/2024/02
Name
Last modified
Size
Description
Parent Directory
-
01-Feb-2021-HTAC-Evaluation-Framework-for-COVID-19-Vaccines.docx-4.pdf
2024-02-29 14:04
181K
06-12-Nov-2021-Weekly-Evidence-Report.pdf
2024-02-28 08:28
490K
4th-Dose-Banner-1-150x150.png
2024-02-26 15:55
17K
4th-Dose-Banner-1-300x114.png
2024-02-26 15:55
26K
4th-Dose-Banner-1-500x191.png
2024-02-26 15:55
55K
4th-Dose-Banner-1-768x293.png
2024-02-26 15:55
100K
4th-Dose-Banner-1-1024x390.png
2024-02-26 15:55
143K
4th-Dose-Banner-1-1536x585.png
2024-02-26 15:55
241K
4th-Dose-Banner-1-2048x781.png
2024-02-26 15:55
347K
4th-Dose-Banner-1.png
2024-02-26 15:55
1.0M
20221020_131933-1-2048x1536-1-150x150.jpg
2024-02-13 15:58
7.7K
20221020_131933-1-2048x1536-1-300x225.jpg
2024-02-13 15:58
18K
20221020_131933-1-2048x1536-1-500x375.jpg
2024-02-13 15:58
41K
20221020_131933-1-2048x1536-1-768x576.jpg
2024-02-13 15:58
81K
20221020_131933-1-2048x1536-1-1024x768.jpg
2024-02-13 15:58
133K
20221020_131933-1-2048x1536-1-1536x1152.jpg
2024-02-13 15:58
247K
20221020_131933-1-2048x1536-1.jpg
2024-02-13 15:58
409K
ANNEX-A_Guidance-Document-on-RATs_01-August-2020.pdf
2024-02-27 13:08
581K
Advisory-Announcement-on-the-Call-for-Nominations-for-2023-17-Feb-2023.docx.pdf
2024-02-29 10:26
204K
Advisory-Consultative-Meeting-for-Administrative-Order-2020-0041.pdf
2024-02-29 13:21
639K
Advisory-Dapagliflozin-PNF-Inclusion-for-T2DM-Patients.docx-3.pdf
2024-02-28 11:06
130K
Advisory-HTAC-Preliminary-Recommendation-on-Insulin-Glargine-and-Insulin-Detemir-for-T1DM-and-T2DM.docx.pdf
2024-02-22 16:00
501K
Advisory-Stakeholder-engagement-following-the-transfer-of-the-HTA-implementation-from-the-DOH-to-the-DOST-March-2023.pdf
2024-02-28 10:59
464K
Advisory-Topic-Nomination-and-Prio-Guidelines-PubCon-28-July-2023.docx-1.pdf
2024-02-28 10:30
253K
Advisory_-Preliminary-Recommendation-on-Eribulin-mSTS.pdf
2024-02-22 16:07
744K
Advisory_-Preliminary-Recommendation-on-Pertuzumab-for-HER2-breast-cancer.pdf
2024-02-22 13:49
262K
Advisory_-Preliminary-Recommendation-on-Rituximab-for-non-Hodgkins-Lymphoma.pdf
2024-02-22 14:52
500K
Annabelle-150x150.png
2024-02-06 11:35
40K
Annabelle.png
2024-02-06 11:35
126K
Annex-A-Evidence-Summary-on-Pazopanib-for-mSTS.docx-1.pdf
2024-02-27 11:17
252K
Annex-A_Rapid-Review-on-ECMO-10-September-2020.pdf
2024-02-27 13:03
2.4M
Annex-B_-Rapid-Review-on-RATs_27-July-2020.pdf
2024-02-27 13:08
5.7M
Annex-B_Evidence-Summary-on-ECMO-10-September-2020.pdf
2024-02-27 13:03
306K
Annex-C_-Evidence-Summary-V2HTAC_01-August-2020.pdf
2024-02-27 13:08
226K
Annex-second-booster-for-the-individuals-ages-18-to-49-years-without-comorbidities.pdf
2024-02-29 10:39
168K
C19-Drugs-Banner-150x150.png
2024-02-26 16:32
11K
C19-Drugs-Banner-300x108.png
2024-02-26 16:32
17K
C19-Drugs-Banner-500x180.png
2024-02-26 16:32
36K
C19-Drugs-Banner-768x277.png
2024-02-26 16:32
58K
C19-Drugs-Banner-1024x369.png
2024-02-26 16:32
84K
C19-Drugs-Banner.png
2024-02-26 16:32
54K
CORESIA-Vaccine-Certificate-Survey-for-Key-Stakeholders.pdf
2024-02-29 11:16
2.5M
Covovax_GenPop_Cover-150x150.png
2024-02-29 13:12
32K
Covovax_GenPop_Cover-300x114.png
2024-02-29 13:12
49K
Covovax_GenPop_Cover-500x191.png
2024-02-29 13:12
131K
Covovax_GenPop_Cover-768x293.png
2024-02-29 13:12
299K
Covovax_GenPop_Cover-1024x390.png
2024-02-29 13:12
523K
Covovax_GenPop_Cover-1536x585.png
2024-02-29 13:12
1.1M
Covovax_GenPop_Cover-2048x781.png
2024-02-29 13:12
2.0M
Covovax_GenPop_Cover.png
2024-02-29 13:12
9.9M
Cycloferon_Evidence-Summary.pdf
2024-02-27 13:37
88K
DC-2021-0468-HTAC-Recommendations-on-Pediatric-Vaccination.pdf
2024-02-29 09:31
1.3M
DC-2021-0471.pdf
2024-02-29 11:28
1.1M
DC-2022-0593-Inclusion-of-Remdesivir-for-Adult-in-the-PNF.pdf
2024-02-29 10:51
47M
DC-No.-2021-0075.pdf
2024-02-29 11:04
1.0M
DC-No.-2021-0273.pdf
2024-02-29 10:22
727K
DC-No.-2021-0331.pdf
2024-02-29 10:28
721K
DC-No.-2021-0337-1.pdf
2024-02-29 10:29
697K
DC-No.-2021-0376.pdf
2024-02-29 11:08
1.2M
DC-No.-2023-0060-Epoetin-Alfa.pdf
2024-02-28 10:51
6.5M
DC-No.-2023-0061-Filgrastim.pdf
2024-02-28 10:56
5.5M
DC_2021-0410_Inclusion_of_Two-Dose_Inactivated_Polio_Vaccine_in_the_PNF.pdf
2024-02-29 10:26
3.5M
DC_NO._2021-0400_TLD-PNF-INclusion.pdf
2024-02-29 10:42
1.0M
DC_NO._2021-0423_INCLUSION_OF_DOLUTEGRAVIR_DTG_IN_THE_PHILIPPINE_NATIONAL_FORMULARY_PNF.pdf
2024-02-29 13:51
1.4M
DM-2021-0242-DM-on-the-inclusion-of-NRT-and-Varenicline-in-the-Primary-Care-Formulary.pdf
2024-02-29 10:48
3.2M
DM-No.-2021-0097.pdf
2024-02-29 10:58
950K
DM-No.-2021-0264.pdf
2024-02-29 09:57
573K
DM-No.-2021-0294-Non-inclusion-of-Lapatinib-in-the-PNF.pdf
2024-02-29 10:43
666K
DM-No.-2021-0317-NON-INCLUSION-OF-PAZOPANIB-AS-A-SECOND-LINE-TREATMENT-FOR-METASTATIC-SOFT-TISSUE-SARCOMA-mSTS-IN-THE-PHILIPPINE-NATIONAL-FORMULARY.pdf
2024-02-29 09:45
1.1M
DM-No.-2021-0367-Dtrak-104563-HEALTH-TECHNOLOGY-ASSESSMENT-COUNCILS-HTAC-UPDATED-RECOMMENDATIONS-ON-COVID-19-VACCINE-SINOVAC.pdf
2024-02-29 10:41
574K
DM-No.2021-0227.pdf
2024-02-29 10:51
591K
DOH-Department-Circular-Submission-of-Data-of-COVID-19-Vaccines-under-EUA.pdf
2024-02-29 14:06
133K
DOH-Releases-New-Implementing-Guidelines-on-HTA-150x150.png
2024-02-13 15:56
18K
DOH-Releases-New-Implementing-Guidelines-on-HTA-300x116.png
2024-02-13 15:56
46K
DOH-Releases-New-Implementing-Guidelines-on-HTA-500x194.png
2024-02-13 15:56
102K
DOH-Releases-New-Implementing-Guidelines-on-HTA-768x298.png
2024-02-13 15:56
205K
DOH-Releases-New-Implementing-Guidelines-on-HTA-1024x397.png
2024-02-13 15:56
329K
DOH-Releases-New-Implementing-Guidelines-on-HTA-1536x595.png
2024-02-13 15:56
642K
DOH-Releases-New-Implementing-Guidelines-on-HTA-2048x794.png
2024-02-13 15:56
1.0M
DOH-Releases-New-Implementing-Guidelines-on-HTA.png
2024-02-13 15:56
2.4M
DRAFT-DM-METHODS-FOR-SELECTION-OF-MEDICAL-DEVICES-FOR-PEMDL.pdf
2024-02-28 13:28
219K
DRAFT-PEMDL-2022.pdf
2024-02-28 13:28
1.3M
Department-Circular-No.-2021-0079-HTAC-Recommendations-on-Health-Technologies-Requiring-Full-CPR-from-the-FDA-1-1.pdf
2024-02-29 11:00
655K
Department-Circular-No.-2021-0079-HTAC-Recommendations-on-Health-Technologies-Requiring-Full-CPR-from-the-FDA-1.pdf
2024-02-29 09:56
655K
Department-Memorandum-No.-2020-0366-Inclusion-of-10-and-13-valent-Pneumococcal-Conjugate-Vaccines-PCV-multidose-preparation-in-the-Philippine-National-Formulary.pdf
2024-02-29 11:05
130K
Department-Memorandum-No.-2021-0079-Endorsement-of-Topic-Submissions-from-National-Health-Programs-for-HTA-2.pdf
2024-02-29 11:01
518K
Dr.-Calimag--150x150.png
2024-02-06 13:49
54K
Dr.-Calimag-.png
2024-02-06 13:49
180K
Dr.-Cayad-an-150x150.png
2024-02-06 11:35
37K
Dr.-Cayad-an.png
2024-02-06 11:35
115K
Dr.-Delos-Santos-150x150.png
2024-02-06 11:35
36K
Dr.-Delos-Santos.png
2024-02-06 11:35
114K
Dr.-Mantaring-150x150.png
2024-02-06 13:50
34K
Dr.-Mantaring.png
2024-02-06 13:50
105K
Dr.-Rogado-150x150.png
2024-02-06 11:35
36K
Dr.-Rogado.png
2024-02-06 11:35
117K
Dr.-Tan-150x150.png
2024-02-06 11:35
34K
Dr.-Tan.png
2024-02-06 11:35
104K
Dtrak-47419-DM-No.2021-0199.pdf
2024-02-29 10:55
1.2M
ES-Covovax.pdf
2024-02-27 08:27
435K
ES-Pfizer-Pedia-5-to-11-yo-SOH-Approved-03-Feb-2022-.pdf
2024-02-26 16:20
1.1M
ES_Huawei-Cloud-AI-Assisted-Diagnosis-for-COVID-19.pdf
2024-02-27 13:30
147K
ES_Moderna-Primary-Series-for-6-to-11-yo.pdf
2024-02-29 10:32
1.0M
ES_Oral-PrEP-for-HIV_as-of-Nov-2021.docx-1.pdf
2024-02-26 16:34
698K
Eribulin-recommendation-150x150.jpg
2024-02-26 10:08
8.4K
Eribulin-recommendation-300x272.jpg
2024-02-26 10:08
27K
Eribulin-recommendation-500x454.jpg
2024-02-26 10:08
72K
Eribulin-recommendation.jpg
2024-02-26 10:08
119K
Events-and-Press-Releases-150x150.png
2024-02-07 08:40
16K
Events-and-Press-Releases.png
2024-02-07 08:40
22K
Evidence-Summary-as-of-04-March-2022-Rituximab-SC-for-non-Hodgkins-lymphoma.pdf
2024-02-22 13:52
794K
Evidence-Summary-on-Booster-and-Additional-Dose-Vaccination-for-the-prevention-of-COVID-19-as-of-03-November-2021.pdf
2024-02-27 08:52
1.6M
Evidence-Summary-on-Janssen-COVID-19-Vaccine-30-April-2021.pdf
2024-02-27 11:01
647K
Evidence-Summary-on-Janssen-COVID-19-Vaccine-Recommendation.pdf
2024-02-27 11:01
158K
Evidence-Summary-on-Zoledronic-Acid-07-Sept-2022.pdf
2024-02-28 15:11
626K
Evidence-Summary_AMTI-uAI-Discover-PNA_April-72020.pdf
2024-02-27 13:28
180K
Evidence_Summary_RT-PCR_Testing_for_COVID-19.pdf
2024-02-27 11:10
1.2M
Favipiravir_Evidence-Summary.pdf
2024-02-27 13:33
92K
Final-Advisory-Cerebrolysin-for-non-PNF-Inclusion-for-stroke.docx.pdf
2024-02-28 10:46
150K
Final-Advisory-DOACs-PNF-Inclusion.docx.pdf
2024-02-28 10:42
146K
For-posting-DM.-NO.-2021-0252-Health-Technology-Assessment-Councils-HTAC-Recommendations_on-RT-PCR-and-Rapid-Antigen-Testing-for-COVID-19.pdf
2024-02-29 10:47
1.7M
For-stakeholder-consultation-ES-Eribulin-for-mSTS-as-of-13-June-2022.pdf
2024-02-22 13:29
332K
For-stakeholder-consultation-Evidence-Summary-on-Insulin-Glargine-and-Insulin-Detemir-for-T1DM-and-T2DM.docx.pdf
2024-02-22 13:39
767K
HCP_Sinovac-Banner-150x150.png
2024-02-29 17:44
9.9K
HCP_Sinovac-Banner-300x116.png
2024-02-29 17:44
18K
HCP_Sinovac-Banner-500x193.png
2024-02-29 17:44
37K
HCP_Sinovac-Banner-768x297.png
2024-02-29 17:44
64K
HCP_Sinovac-Banner-1024x395.png
2024-02-29 17:44
89K
HCP_Sinovac-Banner-1536x593.png
2024-02-29 17:44
145K
HCP_Sinovac-Banner-2048x791.png
2024-02-29 17:44
207K
HCP_Sinovac-Banner.png
2024-02-29 17:44
306K
HTA-Philippines-2019-Annual-Report.pdf
2024-02-07 10:05
1.8M
HTA-Philippines-2020-Annual-Report.pdf
2024-02-07 10:08
1.6M
HTA-Philippines-2021-Annual-Report-.pdf
2024-02-07 10:11
3.7M
HTA-Philippines-Social-Values-Guide-2022.pdf
2024-02-07 09:07
6.5M
HTA-Research-agenda-2021-150x150.png
2024-02-13 15:57
15K
HTA-Research-agenda-2021-300x108.png
2024-02-13 15:57
18K
HTA-Research-agenda-2021-500x180.png
2024-02-13 15:57
34K
HTA-Research-agenda-2021-768x277.png
2024-02-13 15:57
53K
HTA-Research-agenda-2021-1024x369.png
2024-02-13 15:57
77K
HTA-Research-agenda-2021.png
2024-02-13 15:57
51K
HTA-Weekly-Evidence-Report-01-08-January-2021-1.pdf
2024-02-23 16:40
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-2.pdf
2024-02-27 09:07
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-3.pdf
2024-02-27 09:08
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-4.pdf
2024-02-27 09:11
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-5.pdf
2024-02-27 09:15
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-6.pdf
2024-02-27 09:25
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-7.pdf
2024-02-27 09:30
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-8.pdf
2024-02-27 09:34
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-9.pdf
2024-02-27 09:37
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-10.pdf
2024-02-27 09:42
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-11.pdf
2024-02-27 09:46
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-12.pdf
2024-02-27 09:49
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-13.pdf
2024-02-27 09:51
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-14.pdf
2024-02-27 09:54
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-15.pdf
2024-02-27 09:57
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-16.pdf
2024-02-27 10:00
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-17.pdf
2024-02-27 10:04
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-18.pdf
2024-02-27 10:08
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-19.pdf
2024-02-27 10:11
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-20.pdf
2024-02-27 10:13
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-21.pdf
2024-02-27 10:18
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-22.pdf
2024-02-27 10:21
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-23.pdf
2024-02-27 10:25
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-24.pdf
2024-02-27 10:30
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-25.pdf
2024-02-27 10:33
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-26.pdf
2024-02-27 10:40
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-27.pdf
2024-02-27 10:42
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-28.pdf
2024-02-27 10:46
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-29.pdf
2024-02-27 10:48
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-30.pdf
2024-02-27 10:51
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-31.pdf
2024-02-27 10:54
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-32.pdf
2024-02-27 10:56
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-33.pdf
2024-02-27 11:19
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-34.pdf
2024-02-27 11:22
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-35.pdf
2024-02-27 11:24
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-36.pdf
2024-02-27 11:26
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-37.pdf
2024-02-27 11:29
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-38.pdf
2024-02-27 11:31
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-39.pdf
2024-02-27 11:33
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-40.pdf
2024-02-27 11:36
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-41.pdf
2024-02-27 11:39
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-42.pdf
2024-02-27 11:41
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-43.pdf
2024-02-27 11:44
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-44.pdf
2024-02-27 11:46
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-45.pdf
2024-02-27 11:49
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-46.pdf
2024-02-27 11:51
868K
HTA-Weekly-Evidence-Report-01-08-January-2021-47.pdf
2024-02-27 11:53
868K
HTA-Weekly-Evidence-Report-01-08-January-2021.pdf
2024-02-23 16:18
868K
HTA-Weekly-Evidence-Report-01-to-07-July-2022.pdf
2024-02-27 08:28
469K
HTA-Weekly-Evidence-Report-01-to-07-May-2021.pdf
2024-02-28 09:50
428K
HTA-Weekly-Evidence-Report-02-to-06-May-2022.pdf
2024-02-27 09:11
498K
HTA-Weekly-Evidence-Report-02-to-08-October-2021.pdf
2024-02-28 08:37
457K
HTA-Weekly-Evidence-Report-03-to-09-September-2022-1.pdf
2024-02-23 15:42
493K
HTA-Weekly-Evidence-Report-03-to-09-September-2022.pdf
2024-02-23 15:27
493K
HTA-Weekly-Evidence-Report-04-to-10-April-2022.pdf
2024-02-27 09:29
452K
HTA-Weekly-Evidence-Report-04-to-10-December-2021.pdf
2024-02-28 08:19
523K
HTA-Weekly-Evidence-Report-04-to-10-June-2022.pdf.pdf
2024-02-27 08:59
523K
HTA-Weekly-Evidence-Report-04-to-10-September-2021.pdf
2024-02-28 08:56
472K
HTA-Weekly-Evidence-Report-05-to-09-July-2021.pdf
2024-02-28 09:34
428K
HTA-Weekly-Evidence-Report-06-to-12-August-2022.pdf
2024-02-23 16:51
500K
HTA-Weekly-Evidence-Report-06-to-12-March-2021.pdf
2024-02-27 11:53
442K
HTA-Weekly-Evidence-Report-07-13-November-2020.pdf
2024-02-27 10:55
447K
HTA-Weekly-Evidence-Report-07-to-13-August-2021-1.pdf
2024-02-28 09:14
507K
HTA-Weekly-Evidence-Report-07-to-13-February-2022.pdf
2024-02-27 09:53
449K
HTA-Weekly-Evidence-Report-07-to-14-March-2022.pdf
2024-02-29 08:38
455K
HTA-Weekly-Evidence-Report-08-to-14-July-2022.pdf
2024-02-27 08:22
473K
HTA-Weekly-Evidence-Report-08-to-14-May-2021.pdf
2024-02-28 09:49
435K
HTA-Weekly-Evidence-Report-09-to-13-May-2022.pdf
2024-02-27 09:09
534K
HTA-Weekly-Evidence-Report-09-to-15-October-2021.pdf
2024-02-28 08:35
468K
HTA-Weekly-Evidence-Report-09-to-16-Apri-2021.pdf
2024-02-28 10:00
441K
HTA-Weekly-Evidence-Report-2-to-7-January-2022.pdf
2024-02-27 10:10
452K
HTA-Weekly-Evidence-Report-4-to-12-February-2021-1.pdf
2024-02-28 09:22
891K
HTA-Weekly-Evidence-Report-4-to-12-February-2021.pdf
2024-02-28 09:14
891K
HTA-Weekly-Evidence-Report-5-to-11-Dec-2020.pdf
2024-02-27 10:48
449K
HTA-Weekly-Evidence-Report-9-to-15-January-2021-1.pdf
2024-02-28 08:56
897K
HTA-Weekly-Evidence-Report-9-to-15-January-2021-2.pdf
2024-02-28 09:07
897K
HTA-Weekly-Evidence-Report-9-to-15-January-2021.pdf
2024-02-28 08:53
897K
HTA-Weekly-Evidence-Report-10-to-16-January-2022.pdf
2024-02-27 10:08
481K
HTA-Weekly-Evidence-Report-10-to-16-July-2021.pdf
2024-02-28 09:29
432K
HTA-Weekly-Evidence-Report-11-to-17-April-2022-1.pdf
2024-02-27 09:27
459K
HTA-Weekly-Evidence-Report-11-to-17-April-2022.pdf
2024-02-27 09:26
459K
HTA-Weekly-Evidence-Report-11-to-17-June-2022.pdf.pdf
2024-02-27 08:57
540K
HTA-Weekly-Evidence-Report-11-to-17-September-2021.pdf
2024-02-28 08:55
456K
HTA-Weekly-Evidence-Report-12-to-18-Dec-2020.pdf
2024-02-27 10:47
458K
HTA-Weekly-Evidence-Report-12-to-18-June-2021.pdf
2024-02-28 09:40
439K
HTA-Weekly-Evidence-Report-13-to-17-December-2021.pdf
2024-02-28 08:16
488K
HTA-Weekly-Evidence-Report-13-to-19-August-2022.pdf
2024-02-23 16:36
462K
HTA-Weekly-Evidence-Report-13-to-19-February-2021.pdf
2024-02-28 09:22
434K
HTA-Weekly-Evidence-Report-13-to-19-March-2021.pdf
2024-02-27 11:54
436K
HTA-Weekly-Evidence-Report-13-to-19-November-2021.pdf
2024-02-28 08:24
463K
HTA-Weekly-Evidence-Report-14-20-November-2020.pdf
2024-02-27 10:53
467K
HTA-Weekly-Evidence-Report-14-to-20-August-2021.pdf
2024-02-28 09:12
497K
HTA-Weekly-Evidence-Report-14-to-20-February-2022.pdf
2024-02-27 09:51
473K
HTA-Weekly-Evidence-Report-14-to-20-March-2022-2.pdf
2024-02-27 09:36
482K
HTA-Weekly-Evidence-Report-14-to-20-March-2022.pdf
2024-02-27 08:13
482K
HTA-Weekly-Evidence-Report-15-to-21-July-2022.pdf
2024-02-27 08:16
474K
HTA-Weekly-Evidence-Report-15-to-21-May-2021.pdf
2024-02-28 09:47
436K
HTA-Weekly-Evidence-Report-16-to-20-May-2022-1.pdf
2024-02-27 09:08
486K
HTA-Weekly-Evidence-Report-16-to-20-May-2022.pdf
2024-02-27 09:06
486K
HTA-Weekly-Evidence-Report-16-to-22-January-2021.pdf
2024-02-28 08:57
917K
HTA-Weekly-Evidence-Report-16-to-22-October-2021.pdf
2024-02-28 08:34
497K
HTA-Weekly-Evidence-Report-17-to-23-April-2021.pdf
2024-02-28 09:59
432K
HTA-Weekly-Evidence-Report-17-to-23-January-2022.pdf
2024-02-27 10:05
477K
HTA-Weekly-Evidence-Report-17-to-23-July-2021.pdf
2024-02-28 09:25
425K
HTA-Weekly-Evidence-Report-18-September-to-24-September-2021.pdf
2024-02-28 08:45
485K
HTA-Weekly-Evidence-Report-18-to-24-April-2022.pdf
2024-02-27 09:22
469K
HTA-Weekly-Evidence-Report-18-to-24-June-2022.pdf
2024-02-27 08:53
501K
HTA-Weekly-Evidence-Report-19-to-25-June-2021.pdf
2024-02-28 09:38
437K
HTA-Weekly-Evidence-Report-19-to-29-Dec-2020-1.pdf
2024-02-27 10:45
443K
HTA-Weekly-Evidence-Report-19-to-29-Dec-2020.pdf
2024-02-27 10:42
443K
HTA-Weekly-Evidence-Report-20-December-to-31-December-2021.pdf
2024-02-27 10:12
479K
HTA-Weekly-Evidence-Report-20-February-to-06-March-2022.pdf
2024-02-27 09:48
492K
HTA-Weekly-Evidence-Report-20-to-26-August-2022.pdf
2024-02-23 16:19
516K
HTA-Weekly-Evidence-Report-20-to-26-February-2021.pdf
2024-02-27 11:49
438K
HTA-Weekly-Evidence-Report-20-to-26-March-2021.pdf
2024-02-28 09:57
435K
HTA-Weekly-Evidence-Report-20-to-26-November-2021.pdf
2024-02-28 08:23
455K
HTA-Weekly-Evidence-Report-21-27-Nov-2020.pdf
2024-02-27 10:51
965K
HTA-Weekly-Evidence-Report-21-to-27-August-2021.pdf
2024-02-28 09:08
456K
HTA-Weekly-Evidence-Report-21-to-27-February-2022.pdf
2024-02-27 09:50
460K
HTA-Weekly-Evidence-Report-21-to-27-March-2022.pdf
2024-02-27 09:34
451K
HTA-Weekly-Evidence-Report-21-to-27-May-2022.pdf
2024-02-27 09:02
476K
HTA-Weekly-Evidence-Report-23-to-29-January-2021.pdf
2024-02-28 09:03
915K
HTA-Weekly-Evidence-Report-23-to-29-October-2021-1.pdf
2024-02-28 08:32
463K
HTA-Weekly-Evidence-Report-24-to-30-April-2021.pdf
2024-02-28 09:58
442K
HTA-Weekly-Evidence-Report-24-to-30-January-2022.pdf
2024-02-27 09:57
474K
HTA-Weekly-Evidence-Report-24-to-30-July-2021.pdf
2024-02-28 09:19
462K
HTA-Weekly-Evidence-Report-24-to-30-June-2022.pdf
2024-02-27 08:32
518K
HTA-Weekly-Evidence-Report-25-April-to-01-May-2022.pdf
2024-02-27 09:14
495K
HTA-Weekly-Evidence-Report-25-September-to-01-October-2021.pdf
2024-02-28 08:42
480K
HTA-Weekly-Evidence-Report-26-June-to-02-July-2021.pdf
2024-02-27 11:43
439K
HTA-Weekly-Evidence-Report-27-August-to-02-September-2022.pdf
2024-02-23 16:06
473K
HTA-Weekly-Evidence-Report-27-February-to-05-March-2021.pdf
2024-02-27 11:51
432K
HTA-Weekly-Evidence-Report-27-March-to-08-Apri-l2021.pdf
2024-02-28 10:00
432K
HTA-Weekly-Evidence-Report-27-November-to-03-December-2021.pdf
2024-02-28 08:20
474K
HTA-Weekly-Evidence-Report-28-August-to-03-Septeber-2021.pdf
2024-02-28 08:15
453K
HTA-Weekly-Evidence-Report-28-March-to-03-April-2022.pdf
2024-02-27 09:32
459K
HTA-Weekly-Evidence-Report-28-May-to-03-June-2022.pdf
2024-02-27 09:00
492K
HTA-Weekly-Evidence-Report-28-Nov-04-Dec-2020.pdf
2024-02-27 10:50
440K
HTA-Weekly-Evidence-Report-29-May-to-04-June-2021.pdf
2024-02-28 09:45
436K
HTA-Weekly-Evidence-Report-30-January-to-03-February-2021-1.pdf
2024-02-28 09:13
903K
HTA-Weekly-Evidence-Report-30-January-to-03-February-2021.pdf
2024-02-28 09:09
903K
HTA-Weekly-Evidence-Report-30-July-to-05-August-2022.pdf
2024-02-23 16:56
468K
HTA-Weekly-Evidence-Report-30-October-to-05-November-2021.pdf
2024-02-28 08:30
481K
HTA-Weekly-Evidence-Report-31-January-to-6-February-2022.pdf
2024-02-27 09:55
495K
HTA-Weekly-Evidence-Report-31-July-to-06-August-2021.pdf
2024-02-28 09:18
479K
HTA-Weekly-Evidence-Report-31-Oct-06-Nov-2020.pdf
2024-02-27 10:54
450K
HTA-_-COVID-150x150.png
2024-02-13 15:56
8.8K
HTA-_-COVID-300x114.png
2024-02-13 15:56
14K
HTA-_-COVID-500x191.png
2024-02-13 15:56
25K
HTA-_-COVID-768x293.png
2024-02-13 15:56
41K
HTA-_-COVID-1024x391.png
2024-02-13 15:56
60K
HTA-_-COVID-1536x586.png
2024-02-13 15:56
111K
HTA-_-COVID-2048x781.png
2024-02-13 15:56
171K
HTA-_-COVID.png
2024-02-13 15:56
3.1M
HTAC-Approved-ES_AstraZeneca.pdf
2024-02-29 13:56
1.0M
HTAC-Evaluation-Framework-for-COVID-19-Vaccines.pdf
2024-02-29 10:41
181K
HTAC-Evidence-Summary-2nd-Booster-50-and-above-and-18-49-with-comorbidities.pdf
2024-02-26 09:54
708K
HTAC-Interim-Recommendations-on-Pediatric-Vaccination-for-2022-COVID-19-Vaccine-Implementation-with-Annex.pdf
2024-02-29 14:03
862K
HTAC-PRESS-RELEASE-25-NOVEMBER-2022-English-Version.pdf
2024-02-29 14:55
137K
HTAC-PRESS-RELEASE-25-NOVEMBER-2022-Filipino-version.pdf
2024-02-29 14:55
137K
HTAC-Recommendation-on-Rapid-Antibody-Based-Tests-for-COVID-19_-as-of-01-August-2020.pdf
2024-02-27 13:08
6.6M
HTAC-pool-of-experts_Department-Personnel-Order-2021-2780-1.pdf
2024-02-29 10:35
102K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-150x150.jpg
2024-02-26 10:07
4.9K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-300x134.jpg
2024-02-26 10:07
9.2K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-500x223.jpg
2024-02-26 10:07
23K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-768x343.jpg
2024-02-26 10:07
49K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-1024x457.jpg
2024-02-26 10:07
75K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-1536x686.jpg
2024-02-26 10:07
135K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357-2048x914.jpg
2024-02-26 10:07
192K
HTACRecomm_InsulineGlargineandDetemir-scaled-e1665457051357.jpg
2024-02-26 10:07
257K
HTACStocktaking_67-150x150.jpg
2024-02-13 16:00
9.4K
HTACStocktaking_67-300x157.jpg
2024-02-13 16:00
17K
HTACStocktaking_67-500x261.jpg
2024-02-13 16:00
39K
HTACStocktaking_67-768x401.jpg
2024-02-13 16:00
78K
HTACStocktaking_67-1024x535.jpg
2024-02-13 16:00
125K
HTACStocktaking_67-1536x802.jpg
2024-02-13 16:00
228K
HTACStocktaking_67.jpg
2024-02-13 16:00
510K
IGP-150x150.png
2024-02-06 11:35
35K
IGP.png
2024-02-06 11:35
107K
Janssen-HCP-150x150.png
2024-02-29 17:15
8.8K
Janssen-HCP-300x114.png
2024-02-29 17:15
14K
Janssen-HCP-500x191.png
2024-02-29 17:15
28K
Janssen-HCP-768x293.png
2024-02-29 17:15
47K
Janssen-HCP-1024x390.png
2024-02-29 17:15
66K
Janssen-HCP-1536x585.png
2024-02-29 17:15
104K
Janssen-HCP-2048x781.png
2024-02-29 17:15
144K
Janssen-HCP.png
2024-02-29 17:15
194K
MEMO-DOH-PROGRAMS-and-PHIC-ON-TOPIC-NOMINATION-DEADLINE.pdf
2024-02-29 13:19
135K
MI-PC-Banner-150x150.png
2024-02-26 15:48
12K
MI-PC-Banner-300x82.png
2024-02-26 15:48
16K
MI-PC-Banner-500x137.png
2024-02-26 15:48
34K
MI-PC-Banner-768x210.png
2024-02-26 15:48
58K
MI-PC-Banner-1024x280.png
2024-02-26 15:48
86K
MI-PC-Banner.png
2024-02-26 15:48
42K
Memo-on-Minor-Inclusions.pdf
2024-02-29 13:23
135K
Memo-to-DOH-Internal-Offices-Acknowledgement-of-Comments_Concurrence-on-COVID-19-Vaccines-Evaluation-Framework.pdf
2024-02-29 14:05
147K
Memo-to-DOH-Internal-Offices-Consultation-for-COVID-19-Vaccines-Evaluation-Framework.pdf
2024-02-29 10:14
146K
Minor_Inclusions_-_Banner-150x150.png
2024-02-26 10:30
6.8K
Minor_Inclusions_-_Banner-300x82.png
2024-02-26 10:30
12K
Minor_Inclusions_-_Banner-500x137.png
2024-02-26 10:30
27K
Minor_Inclusions_-_Banner-768x210.png
2024-02-26 10:30
45K
Minor_Inclusions_-_Banner-1024x280.png
2024-02-26 10:30
67K
Minor_Inclusions_-_Banner.png
2024-02-26 10:30
55K
Ms.-Lee-150x150.png
2024-02-06 11:35
38K
Ms.-Lee.png
2024-02-06 11:35
121K
OIC-SOH-Approved-ES-Eribulin-for-mSTS-as-of-May-2022.pdf
2024-02-26 10:09
332K
PCV-ES-OSEC-approved.pdf
2024-02-27 13:23
1.9M
PCV-Full-HTA-Report-FINAL-.pdf
2024-02-27 13:23
4.1M
PHE-COVID-19-MPX-Evidence-Brief-DEC-24-31.pdf
2024-02-23 13:30
562K
PR-DOH-OFFICIALLY-TRANSFERS-OPERATIONS-OF-HTA-TO-DOST-RECOGNIZING-PARTNERSHIP-AND-NETWORK-FOR-STRENGTHENED-HEALTH-TECHNOLOGY-CAPACITY.pdf
2024-02-28 10:59
413K
Picture-DOH-holds-first-HTA-public-consultation-2-150x150.png
2024-02-13 15:55
7.5K
Picture-DOH-holds-first-HTA-public-consultation-2-300x170.png
2024-02-13 15:55
20K
Picture-DOH-holds-first-HTA-public-consultation-2-500x283.png
2024-02-13 15:55
42K
Picture-DOH-holds-first-HTA-public-consultation-2.png
2024-02-13 15:55
41K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-150x150.jpg
2024-02-13 15:55
6.2K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-300x204.jpg
2024-02-13 15:55
14K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-500x339.jpg
2024-02-13 15:55
30K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1-768x521.jpg
2024-02-13 15:55
58K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-1.jpg
2024-02-13 15:55
95K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-150x150.jpg
2024-02-13 16:05
6.2K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-300x204.jpg
2024-02-13 16:05
14K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-500x339.jpg
2024-02-13 16:05
30K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2-768x521.jpg
2024-02-13 16:05
58K
Picture-DOH-holds-high-level-forum-to-accelerate-HTA-1024x695-2.jpg
2024-02-13 16:05
95K
PrevProm-Chair-Dr.-Abrogena-150x150.png
2024-02-06 13:37
30K
PrevProm-Chair-Dr.-Abrogena.png
2024-02-06 13:37
93K
RDT_edited-Evidence-Summary.pdf
2024-02-27 13:39
301K
RR_Favipiravir-Avigan.pdf
2024-02-27 13:33
1.6M
RR_IgG.IgM-RDT-Kits.pdf
2024-02-27 13:39
1.7M
RR_MA-Cycloferon.pdf
2024-02-27 13:37
1.7M
RR_RT-PCR_HTAU.PPE_.03.08.2020_FINAL.pdf
2024-02-27 13:26
1.5M
SOH-Approved-Evidence-Summary-of-Rituximab-SC-as-of-July-2022-Recommendation.pdf
2024-02-26 10:02
74K
SOH-Approved-Evidence-Summary-of-Rituximab-SC-as-of-July-2022.pdf
2024-02-26 10:01
1.0M
Sambong_250mg_Banner-150x150.png
2024-02-26 16:27
10K
Sambong_250mg_Banner-300x82.png
2024-02-26 16:27
15K
Sambong_250mg_Banner-500x137.png
2024-02-26 16:27
31K
Sambong_250mg_Banner-768x210.png
2024-02-26 16:27
52K
Sambong_250mg_Banner-1024x280.png
2024-02-26 16:27
75K
Sambong_250mg_Banner.png
2024-02-26 16:27
39K
Signed-HTAC-Letter-from-Office-of-the-Secretary-on-ECMO-14-September-2020.pdf
2024-02-27 13:03
4.1M
Signed-by-OSEC-HTAC-Recommendations-on-Booster-and-Additional-Dose.pdf
2024-02-29 14:02
1.7M
Signed-by-SOH-September-Updates-on-the-2021-HTAC-Recommendations-for-Rapid-Antigen-Testing-merged.pdf
2024-02-29 13:50
538K
Sinpharm_HCP_Cover-150x150.png
2024-02-29 16:10
34K
Sinpharm_HCP_Cover-300x114.png
2024-02-29 16:10
51K
Sinpharm_HCP_Cover-500x191.png
2024-02-29 16:10
141K
Sinpharm_HCP_Cover-768x293.png
2024-02-29 16:10
328K
Sinpharm_HCP_Cover-1024x390.png
2024-02-29 16:10
584K
Sinpharm_HCP_Cover-1536x585.png
2024-02-29 16:10
1.3M
Sinpharm_HCP_Cover-2048x781.png
2024-02-29 16:10
2.3M
Sinpharm_HCP_Cover.png
2024-02-29 16:10
11M
Summary-of-Findings-HTAC-Recommendation-on-2nd-booster-for-individuals-ages-185-49-years-old-without-comorbidities.pdf
2024-02-29 10:39
30K
Trad-Med-Chair-Dr.-Sia-150x150.png
2024-02-06 13:37
30K
Trad-Med-Chair-Dr.-Sia.png
2024-02-06 13:37
95K
Vasopressin_-_Banner-150x150.png
2024-02-26 16:18
9.4K
Vasopressin_-_Banner-300x82.png
2024-02-26 16:18
14K
Vasopressin_-_Banner-500x137.png
2024-02-26 16:18
30K
Vasopressin_-_Banner-768x210.png
2024-02-26 16:18
51K
Vasopressin_-_Banner-1024x280.png
2024-02-26 16:18
76K
Vasopressin_-_Banner.png
2024-02-26 16:18
59K
Vax-2022-Pedia-ES_For-HTAC.pdf
2024-02-29 13:34
1.1M
WEBHC-teaser-photo-150x150.jpg
2024-02-13 15:57
7.3K
WEBHC-teaser-photo-300x197.jpg
2024-02-13 15:57
15K
WEBHC-teaser-photo-500x328.jpg
2024-02-13 15:57
33K
WEBHC-teaser-photo-768x504.jpg
2024-02-13 15:57
61K
WEBHC-teaser-photo-1024x673.jpg
2024-02-13 15:57
92K
WEBHC-teaser-photo-1536x1009.jpg
2024-02-13 15:57
162K
WEBHC-teaser-photo.jpg
2024-02-13 15:57
229K
agnette-peralta-150x150.png
2024-02-06 11:29
44K
agnette-peralta.png
2024-02-06 11:29
144K
dc2020-0011_Non-exemption_in_the_PNF.pdf
2024-02-29 10:02
101K
dm2021-0158-PNF-inlcusion-of-Na-Hyaluronate-and-PD-Solution.pdf
2024-02-29 10:56
140K
doc-peng-150x150.png
2024-02-06 13:28
30K
doc-peng.png
2024-02-06 13:28
89K
dosthtad1-150x150.png
2024-02-29 11:01
46K
dosthtad1-300x196.png
2024-02-29 11:01
113K
dosthtad1-500x327.png
2024-02-29 11:01
293K
dosthtad1-768x502.png
2024-02-29 11:01
636K
dosthtad1.png
2024-02-29 11:01
735K
dosthtad2-150x150.png
2024-02-29 11:01
45K
dosthtad2-300x196.png
2024-02-29 11:01
112K
dosthtad2-500x326.png
2024-02-29 11:01
291K
dosthtad2-768x501.png
2024-02-29 11:01
635K
dosthtad2.png
2024-02-29 11:01
1.0M
dosthtad3-150x150.png
2024-02-29 11:01
46K
dosthtad3-300x196.png
2024-02-29 11:01
108K
dosthtad3-500x326.png
2024-02-29 11:01
274K
dosthtad3-768x501.png
2024-02-29 11:01
587K
dosthtad3.png
2024-02-29 11:01
1.0M
dosthtad4-150x150.png
2024-02-29 11:01
43K
dosthtad4-300x196.png
2024-02-29 11:01
108K
dosthtad4-500x326.png
2024-02-29 11:01
273K
dosthtad4-768x501.png
2024-02-29 11:01
579K
dosthtad4.png
2024-02-29 11:01
677K
dosthtad5-150x150.png
2024-02-29 11:01
54K
dosthtad5-300x159.png
2024-02-29 11:01
114K
dosthtad5-500x265.png
2024-02-29 11:01
299K
dosthtad5-768x406.png
2024-02-29 11:01
656K
dosthtad5.png
2024-02-29 11:01
1.1M
dosthtad6-150x150.png
2024-02-29 11:01
55K
dosthtad6-300x159.png
2024-02-29 11:01
115K
dosthtad6-500x265.png
2024-02-29 11:01
301K
dosthtad6-768x406.png
2024-02-29 11:01
652K
dosthtad6.png
2024-02-29 11:01
1.1M
dosthtad7-150x150.png
2024-02-29 11:01
53K
dosthtad7-300x159.png
2024-02-29 11:01
109K
dosthtad7-500x265.png
2024-02-29 11:01
288K
dosthtad7-768x406.png
2024-02-29 11:01
631K
dosthtad7.png
2024-02-29 11:01
1.1M
dosthtad9-150x150.png
2024-02-29 11:01
45K
dosthtad9-300x225.png
2024-02-29 11:01
126K
dosthtad9-500x375.png
2024-02-29 11:01
312K
dosthtad9.png
2024-02-29 11:01
690K
marita-reyes-150x150.png
2024-02-06 13:12
30K
marita-reyes.png
2024-02-06 13:12
84K
prof-aleth-150x150.png
2024-02-06 13:31
34K
prof-aleth.png
2024-02-06 13:31
104K
slider1-1024x512-1-150x150.png
2024-02-13 15:53
41K
slider1-1024x512-1-300x150.png
2024-02-13 15:53
83K
slider1-1024x512-1-500x250.png
2024-02-13 15:53
211K
slider1-1024x512-1-768x384.png
2024-02-13 15:53
456K
slider1-1024x512-1.png
2024-02-13 15:53
785K
v4-01-March23-Dapagliflozin.pdf
2024-02-28 11:06
534K
vacant_member-150x150.png
2024-02-06 11:26
3.0K
vacant_member.png
2024-02-06 11:26
7.4K
viber_image_2022-10-20_10-46-39-238-1-500x375-1-150x150.jpg
2024-02-29 09:50
9.5K
viber_image_2022-10-20_10-46-39-238-1-500x375-1-300x225.jpg
2024-02-29 09:50
23K
viber_image_2022-10-20_10-46-39-238-1-500x375-1.jpg
2024-02-29 09:50
57K
viber_image_2022-12-15_17-59-04-224-500x889-1-150x150.jpg
2024-02-13 15:59
7.8K
viber_image_2022-12-15_17-59-04-224-500x889-1-169x300.jpg
2024-02-13 15:59
15K
viber_image_2022-12-15_17-59-04-224-500x889-1.jpg
2024-02-13 15:59
90K
Apache/2.4.29 (Ubuntu) Server at hta.dost.gov.ph Port 443